Related Experiment Video
Updated: Jun 1, 2026

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
Published on: October 7, 2017
Implementation of a new CSF dynamic device: a multicenter feasibility study in 562 patients
J Malm1, N Sundström, K G Cesarini
1Department of Clinical Neuroscience, Umeå University, Sweden. jan.malm@neuro.umu.se
The cerebrospinal fluid (CSF) infusion test is a safe procedure for evaluating hydrocephalus, with no serious adverse events reported. Mild to moderate discomfort, such as headache, was observed in a minority of patients.
Area of Science:
- Neurosurgery
- Neurology
- Medical Devices
Background:
- The cerebrospinal fluid (CSF) infusion test is crucial for selecting hydrocephalus patients for shunt surgery.
- Limited data exists on the adverse events associated with this diagnostic procedure.
Purpose of the Study:
- To prospectively evaluate the feasibility and safety of the CSF infusion test.
- To document adverse events during and after the procedure.
Main Methods:
- A prospective study involving 562 patients undergoing CSF infusion testing.
- Standardized devices were used to measure CSF dynamics via lumbar puncture (LP).
- Adverse events and patient discomfort were systematically registered.
Main Results:
- The most common indication was normal-pressure hydrocephalus evaluation (63%).
- Lumbar puncture was successful in most cases, with 4.3% reporting major discomfort.
- 4% of patients experienced severe headache during infusion, and 15% reported headache at 24-h follow-up. No serious adverse events occurred.
Conclusions:
- The CSF infusion test is a safe procedure with a high success rate.
- The investigation is associated with expected mild to moderate discomfort, primarily headaches.
More Related Videos
08:53Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
11:26Home-Based Transcranial Direct Current Stimulation Device Development: An Updated Protocol Used at Home in Healthy Subjects and Fibromyalgia Patients
Published on: July 14, 2018